Watch this on-demand presentation from the Aiforia Investor Event on March 7, 2022 with speakers Jukka Tapaninen, CEO, Veli-Matti Parkkonen, COO, and Kaisa Helminen, COO presenting on Aiforia's key events and financials from 2021, strategic initiatives for 2022 and future outlook.
Invest in the future of AI powered healthcare
Welcome to Aiforia’s investor website! Explore these pages for our latest releases, upcoming events, information on Aiforia as an investment, and more.
Aiforia is a Finnish company providing image analysis software utilising artificial intelligence (“AI”). Aiforia’s business model is based on the development and utilisation of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics.
Aiforia aims to be the global leader in AI-assisted tissue sample analytics.
From empowering researchers in the identification of novel biomarkers of disease, and supporting R&D scientists in speeding up time-to-market of novel drugs, to helping pathologists enhance the accuracy of cancer diagnostics — Aiforia has the expertise and experience to transform healthcare all the way from discovery to diagnosis.
Explore our upcoming events and key dates!
Stay informed by receiving the latest news delivered directly to your inbox!
Subscribe to Aiforia's releases
Aiforia releases another CE-IVD marked clinical AI Model — expanding its diagnostic pathology offering to prostate cancer
PRESS RELEASE | 27 MAY 2022
Why invest in Aiforia
Discover how Aiforia is an investment into the future of AI powered healthcare through its key strengths including its existing AI technology and software solutions, versatile and cloud-based platform, as well as our team of international and highly skilled individuals in technology and life sciences.